Targeting aPKC disables oncogenic signaling by both the EGFR and the proinflammatory cytokine TNFα in glioblastoma
Science Signaling | August 12, 2014 | Volume: 7 | Issue: 338 | Pages: No page available
10.1126/scisignal.2005196
| PMID 25118327
Targeting a kinase common to both the EGFR and TNFα signaling pathways may prevent drug resistance in glioblastoma.